Final Results From a Phase II Trial with the First in Class Recombinant Polyclonal Antibody Product Rozrolimupab in Primary Immune Thrombocytopenia - Robak, Tadeusz; Trelinski, Jacek; Prondzinski, Mario von Depka; Giagounidis, Aristoteles; Doyen, Chantal; Janssens, Ann; Alvarez Roman, Mayte; Loscertales Pueyo, Javier; Jarque Ramos, Isidro; Loscertales, Javier; Perez Rus, Gloria; Hellmann, Andrzej; et al. (Blood, 2011)